Table 5 Site- and age-specific number of cancers and site specific morphologically verified, crude rates and age-standardized rates for females, 2016–2018
Site | ICD-10 | 0–14 | 15–24 | 25–34 | 35–44 | 45–54 | 55–64 | 65–74 | 75 + | Sum | % | MV% | CR | ASR |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Pharynx | C9-11, C12-14 | 0 | 0 | 0 | 1 | 3 | 1 | 0 | 0 | 5 | 0.8 | 100 | 0.2 | 0.1 |
Oesophagus | C15 | 0 | 1 | 0 | 0 | 1 | 1 | 5 | 0 | 8 | 1.4 | 100 | 0.2 | 0.5 |
Stomach | C16 | 0 | 1 | 1 | 2 | 3 | 1 | 3 | 1 | 12 | 2 | 93.3 | 0.5 | 0.8 |
Colon | C18 | 0 | 0 | 1 | 2 | 3 | 6 | 0 | 2 | 14 | 2.4 | 94.7 | 0.7 | 1.4 |
Rectum | C19, C20 | 0 | 0 | 1 | 4 | 2 | 2 | 1 | 1 | 11 | 1.9 | 100 | 0.5 | 0.8 |
Anus | C21 | 0 | 0 | 0 | 0 | 2 | 1 | 3 | 0 | 6 | 1 | 100 | 0.2 | 0.4 |
Liver | C22 | 0 | 0 | 0 | 1 | 0 | 1 | 1 | 1 | 4 | 0.7 | 100 | 0 | 0 |
Pancrease | C25 | 0 | 0 | 1 | 0 | 0 | 2 | 1 | 0 | 4 | 0.7 | 80.0 | 0.2 | 0.4 |
Larynx | C32 | 0 | 0 | 0 | 1 | 0 | 0 | 1 | 0 | 2 | 0.3 | 100 | 0 | 0 |
Trachea bronchus lung | C33, C34 | 0 | 0 | 2 | 2 | 1 | 2 | 4 | 1 | 12 | 2 | 100 | 0.7 | 1.2 |
Melanoma of skin | C43 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 1 | 2 | 0.3 | 100 | 0 | 0 |
Other skin | C44 | 0 | 1 | 1 | 4 | 3 | 3 | 0 | 0 | 12 | 2 | 100 | 0.5 | 1 |
Connective soft tissue | C49 | 0 | 0 | 0 | 0 | 2 | 1 | 1 | 1 | 5 | 0.8 | 100 | 0.2 | 0.3 |
Breast | C50 | 0 | 2 | 19 | 52 | 64 | 41 | 25 | 9 | 212 | 35.8 | 97.9 | 12.4 | 18.8 |
Vagina | C52 | 0 | 0 | 2 | 2 | 2 | 2 | 1 | 2 | 11 | 1.9 | 100 | 0.4 | 0.3 |
Cervix uteri | C53 | 0 | 1 | 5 | 27 | 42 | 42 | 21 | 9 | 147 | 24.8 | 98.5 | 8.9 | 14.5 |
Corpus uteri | C54 | 0 | 0 | 0 | 3 | 6 | 0 | 3 | 0 | 12 | 2 | 100 | 0.7 | 0.9 |
Uterus unspecified | C55 | 0 | 0 | 0 | 5 | 6 | 7 | 2 | 0 | 20 | 3.4 | 92.0 | 1.2 | 2.3 |
Ovary | C56 | 0 | 3 | 4 | 8 | 9 | 3 | 3 | 0 | 30 | 5.1 | 100 | 1.8 | 2.1 |
Kidney | C64, C65 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 1 | 0.2 | 100 | 0 | 0 |
Ureter Bladder | C66-68 | 0 | 0 | 0 | 1 | 1 | 1 | 0 | 2 | 5 | 0.8 | 100 | 0 | 0 |
Brain nervous system | C70-72 | 0 | 0 | 0 | 0 | 1 | 0 | 3 | 0 | 4 | 0.7 | 75.0 | 0.2 | 0.5 |
Thyroid | C73 | 0 | 0 | 2 | 3 | 2 | 0 | 0 | 0 | 7 | 1.2 | 100 | 0.4 | 0.5 |
ill-defined, secondary and unspecified sites | C76,C80 | 0 | 0 | 0 | 1 | 2 | 1 | 2 | 0 | 6 | 1 | 100 | 0.2 | 0.3 |
Hodgkin lymphoma | C81 | 0 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 2 | 0.3 | 100 | 0 | 0 |
Non-Hodgkin lymphoma | C82-85, C96 | 1 | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 3 | 0.5 | 100 | 0 | 0 |
Other and unspecified | Other | 3 | 1 | 1 | 3 | 5 | 7 | 13 | 2 | 35 | 5.9 | 95.7 | 2.1 | 3.8 |
All sites total | 4 | 12 | 40 | 124 | 160 | 127 | 93 | 32 | 592 | 100 | 97.9 | |||
% total | 0.7 | 2 | 6.8 | 20.9 | 27 | 21.5 | 15.7 | 5.4 | 100 |